ACTOS (pioglitazone) – a thiazolidinedione (TZD) and an agonist for peroxisome proliferator activated receptor (PPAR) gamma commonly used to treat type 2 diabetes mellitus. ACTOS decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. Pioglitazone is not an insulin secretagogue. FDA approved uses: […]
SYMBICORT (budesonide and formoterol fumarate dihydrate inhalation) – a metered dose beta agonist-corticosteroid inhaler commonly used to treat asthma or chronic obstructive pulmonary disease . Inflammation is an important component in the development of COPD and asthma. Budesonide is a compound of the corticosteroid classes, members of which possess a wide range of inhibitory activities […]
REBIF (interferon beta-1a) – a interferon beta-1a product commonly used to treat relapsing forms of multiple sclerosis. The specific mechanism by which interferon beta-1a exerts its effects in the treatment of multiple sclerosis has not been fully elucidated. FDA approved uses: Rebif is indicated for the treatment of patients with relapsing forms of multiple sclerosis […]
TRICOR (fenofibrate) – a peroxisome proliferator receptor alpha (PPARα) activator commonly used to treat certain lipid disorders. FDA approved uses: TriCor is indicated as an adjunct to diet – To reduce elevated LDL-C, Total-C, TG and Apo B, and to increase HDL-C in adult patients with primary hypercholesterolemia or mixed dyslipidemia; For treatment of adult […]